---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-009221"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:52:16.857266+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health issues $350K in 6% notes and warrants for 350K shares at $1.00

## Summary
- Issued $350,000 aggregate principal amount of unsecured promissory notes to two accredited investors.
- Notes bear 6% annual interest and mature one month from issuance; prepayable without penalty.
- Investors received warrants to purchase up to 350,000 shares of common stock at $1.00/share, exercisable immediately for five years.
- Proceeds used for working capital and general corporate purposes; transaction closed January 5, 2026.

## SEC filing metadata
- accession: 0001193125-26-009221
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/0001193125-26-009221-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/jagx-20260105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-009221
- JSON: https://secwatch.observer/filing/0001193125-26-009221.json
- Plain text: https://secwatch.observer/filing/0001193125-26-009221.txt

## Key facts
- Debt Financings
  Jaguar Health, Inc. incurred senior notes of $350,000 aggregate principal amount at 6% per annum maturing one month after issuance.
  - Instrument: senior notes
  - Principal: $350,000 aggregate principal amount
  - Rate: 6% per annum
  - Maturity: one month after issuance
  - Event: incurrence
  source text: On January 5, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/0001193125-26-009221-index.htm
- Material Agreements
  Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 (effective 2026-01-05).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: two accredited investors
  - Value: $350,000
  - Effective: 2026-01-05
  source text: On January 5, 2026 (the "Execution Date"), Jaguar Health, Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreements") with two accredited investors (each, an "Investor"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000119312526009221/0001193125-26-009221-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.